Tracked vehiclesAnduril Enterprise 0.87% fill $173.4M / $20BCBP AST 46.50% fill $929.9M / $2.0BPalantir Maven 81.60% fill $637.6M / $781.3MShield AI USCG $61.4M drawn 12 ordersCounter-drone $2.1B drawn 25 C-UAS vehicles and awardsUSAspending compile · Oct 9 2026
AwardTape

AwardTape · Defense awards · Electronics and communications · Instruments and lab equipment · HT942523P0085

HT942523P0085: $0 purchase order to Kilobaser Corp

Kilobaser Corp holds a purchase order from Defense Health Agency with $0 obligated since Oct 2023 and $174K obligated over its life, against a ceiling of $174K. Latest action May 21, 2025.

Three kilobaser one-xt - extended edition benchtop synthesizers for standard and advanced oligonucleotides (modified deoxyribonucleic acid (dna) and ribonucleic acid (rna)).

PIIDHT942523P0085
Typepurchase order
CompanyKilobaser Corp
AgencyDefense Health Agency
Contracting officeARMY MED RES ACQ ACTIVITY
CategoryElectronics and communications · Instruments and lab equipment
PSC6640 LABORATORY EQUIPMENT AND SUPPLIES
NAICS334516 ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Obligated since Oct 2023$0
Total obligated (lifetime)$174K
Ceiling (base and all options)$174K
Base dateAug 30, 2023
Latest actionMay 21, 2025
End dateSep 1, 2029
Actions since Oct 20231
PricingFirm fixed price
CompetitionNot competed
SourceUSAspending.gov record
Reporting lagDoD 90 days
About this record

Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.

Terminal: alerts on new orders and modifications to this contract, and CSV export.

7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.

Start free trial